PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys
Abstract
Dopamine neurotransmission is associated with high susceptibility to cocaine abuse. Positron emission tomography was used in 12 rhesus macaques to determine if dopamine D2 receptor availability was associated with the rate of cocaine reinforcement, and to study changes in brain dopaminergic function during maintenance of and abstinence from cocaine. Baseline D2 receptor availability was negatively correlated with rates of cocaine self-administration. D2 receptor availability decreased by 15-20% within 1 week of initiating self-administration and remained reduced by approximately 20% during 1 year of exposure. Long-term reductions in D2 receptor availability were observed, with decreases persisting for up to 1 year of abstinence in some monkeys. These data provide evidence for a predisposition to self-administer cocaine based on D2 receptor availability, and demonstrate that the brain dopamine system responds rapidly following cocaine exposure. Individual differences in the rate of recovery of D2 receptor function during abstinence were noted.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The decrease in D2 receptor binding is long lasting, at least 3-4 months in humans and possibly up to a year in non-human primates depending on the individual.
“On the other hand, the decrease in D2 receptor binding is long lasting, at least 3–4 months in humans (Volkow et al., 1993) and possibly longer, up to a year in non-human primates depending on the individual (Nader et al., 2006).”
From Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity (2014) · cites this paper as Nader et al., 2006
Repeated drug exposures in rodents and non-human primates are associated with reductions in striatal D2R levels and D2R signalling.
“preclinical studies in rodent and non-human primates have shown that repeated drug exposures are associated with reductions in striatal D2R levels and in D2R signalling (65–67).”
From Obesity and addiction: Neurobiological overlaps (2013) · cites this paper as [66]
Repeated drug exposures are associated with long-lasting reductions in striatal D2R levels and signaling in preclinical studies.
“Similarly, preclinical studies have shown that repeated drug exposures are associated with long-lasting reductions in striatal D2R levels and signaling (72,73).”
From The Addictive Dimensionality of Obesity (2013) · cites this paper as [72]
Preclinical studies in rodent and non-human primates have shown that repeated drug exposures are associated with reductions in striatal D2R levels.
“Similarly, preclinical studies in rodent and non-human primates have shown that repeated drug exposures are associated with reductions in striatal D2R levels (Nader et al 2006;Thanos et al 2007;Volkow et al 2001).”
From Food and Drug Reward: Overlapping Circuits in Human Obesity and Addiction (2011) · cites this paper as Nader et al 2006
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346 · see citing works
Addiction Is a Brain Disease, and It Matters
Leshner, A. I. (1997) · Science · doi:10.1126/science.278.5335.45 · Cited by 1,615 · see citing works
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., HITZEMANN, R. J., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,481 · see citing works
Factors That Predict Individual Vulnerability to Amphetamine Self-Administration
Piazza, P. V., Deminière, J.-M., Moal, M. L., & Simon, H. (1989) · Science · doi:10.1126/science.2781295 · Cited by 1,355 · see citing works
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240 · see citing works
Transition from Moderate to Excessive Drug Intake: Change in Hedonic Set Point
Ahmed, S. H., & Koob, G. F. (1998) · Science · doi:10.1126/science.282.5387.298 · Cited by 1,159 · see citing works
Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction
Koob, G. F., & Le Moal, M. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1442 · Cited by 963 · see citing works
Mintun, M. A., Raichle, M. E., Kilbourn, M. R., Wooten, G. F., & Welch, M. J. (1984) · Annals of Neurology · doi:10.1002/ana.410150302 · Cited by 956 · see citing works
Volkow, N. D., Fowler, J. S., Wang, G., Hitzemann, R., Logan, J., Schlyer, D. J., Dewey, S. L., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890140210 · Cited by 924 · see citing works
The role of stress in drug self-administration
Piazza, P. V., & Moal, M. L. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01115-2 · Cited by 674 · see citing works
Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration
Morgan, D., Grant, K. A., Gage, H. D., Mach, R. H., Kaplan, J. R., Prioleau, O., Nader, S. H., Buchheimer, N., Ehrenkaufer, R. L., & Nader, M. A. (2002) · Nature Neuroscience · doi:10.1038/nn798 · Cited by 674 · see citing works
Self-citationBlum, K. (2017) · Sage eBooks · doi:10.4135/9781483365817.n1156 · Cited by 474 · see citing works
Effects of chronic cocaine abuse on postsynaptic dopamine receptors
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.6.719 · Cited by 421 · see citing works
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Gifford, A., Hitzemann, R., Ding, Y.-S., & Pappas, N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1440 · Cited by 406 · see citing works
Volkow, N. D., Wang, G.-J., Fowler, J. S., Hitzemann, R., Angrist, B., Gatley, S. J., Logan, J., Ding, Y.-S., & Pappas, N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.19 · Cited by 405 · see citing works
Mello, N. K. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00274-h · Cited by 390 · see citing works
Piazza, P. V., Deroche-Gamonent, V., Rougé‐Pont, F., & Moal, M. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04226.2000 · Cited by 353 · see citing works
Martinez, D., Broft, A., Foltin, R. W., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Frankel, W. G., Cooper, T., Kleber, H. D., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300420 · Cited by 306 · see citing works
Neuroscience of Psychoactive Substance Use and Dependence
Mann, K. F. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00906.x · Cited by 300 · see citing works
Goeders, N. E. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.785 · Cited by 286 · see citing works
Neurobiology of addiction: treatment and public policy ramifications
Dackis, C. A., & O’Brien, C. P. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1431 · Cited by 267 · see citing works
Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans
Laruelle, M. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00043-2 · Cited by 266 · see citing works
Madras, B. K., Fahey, M. A., Bergman, J., Canfield, D. R., & Spealman, R. D. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20684-x · Cited by 244 · see citing works
Dewey, S. L., Smith, G., Logan, J., Alexoff, D. L., Ding, Y., King, P., Pappas, N. R., Brodie, J. D., & Ashby, C. R. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00821.1995 · Cited by 215 · see citing works
Dewey, S. L., Smith, G., Logan, J., Brodie, J. D., Yu, D.-W., Ferrieri, R. A., King, P., MacGregor, R. R., Martin, T., & Wolf, A. P. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-10-03773.1992 · Cited by 211 · see citing works
Nader, M. A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00427-4 · Cited by 206 · see citing works
Self-citationKalivas, P. W., & Duffy, P. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90271-0 · Cited by 199 · see citing works
Risk of Becoming Cocaine Dependent: Epidemiological Estimates for the United States, 2000–2001
O’Brien, M. S., & Anthony, J. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300681 · Cited by 198 · see citing works
Drug Self-Administration by Laboratory Animals: Control by Schedules of Reinforcement
Spealman, R. D., & Goldberg, S. R. (1978) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.18.040178.001525 · Cited by 191 · see citing works
Nader, M. A., & Czoty, P. W. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1473 · Cited by 177 · see citing works
Self-citationEffect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys
Moore, R. J., Vinsant, S. L., Nader, M. A., Porrino, L. J., & Friedman, D. P. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199809)30:1 · Cited by 134 · see citing works
Self-citationGrigson, P. S., & Twining, R. C. (2002) · Behavioral Neuroscience · doi:10.1037/0735-7044.116.2.321 · Cited by 125 · see citing works
Testing and evaluation of drugs of abuse
Adler, M. W., & Cowan, A. (1990) · Cited by 110 · see citing works
Saturable (3H)cocaine binding in central nervous system of mouse
Reith, M. E. A., Sershen, H. W., & Lajtha, Á. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90029-6 · Cited by 109 · see citing works
Calabresi, P., Murtas, M. D., & Bernardi, G. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00556-8 · Cited by 107 · see citing works
Acute and Chronic Dopamine Dynamics in a Nonhuman Primate Model of Recreational Cocaine Use
Bradberry, C. W. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-18-07109.2000 · Cited by 97 · see citing works
Emergency Department Trends From the Drug Abuse Warning Network, Final Estimates 1995-2002
(2003) · PsycEXTRA Dataset · doi:10.1037/e433812005-001 · Cited by 73 · see citing works
Experimental evaluation of the reinforcing effects of drugs.
Woolverton, W. L., & Nader, M. A. (1990) · Cited by 63 · see citing works
Self-citationZernig, G., Wakonigg, G., Madlung, E., et al. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1601-0 · Cited by 56 · see citing works
Mach, R. H., Nader, M. A., Ehrenkaufer, R. L., Line, S. W., Smith, C. R., Gage, H. D., & Morton, T. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00449-2 · Cited by 48 · see citing works
Self-citationMach, R. H., Leudtke, R. R., UNSWORTH, C. D., et al. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00075a028 · Cited by 45 · see citing works
Self-citationMach, R. H., Elder, S. T., Morton, T. E., et al. (1993) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(93)90165-q · Cited by 41 · see citing works
Self-citationMach, R. H., Nader, M. A., Ehrenkaufer, R. L., Line, S. W., Smith, C. R., Luedtke, R. R., Kung, M., Kung, H. F., Huston-Lyons, D., & Morton, T. E. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199612)24:4 · Cited by 30 · see citing works
Self-citationNader, M. A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00101-8 · Cited by 29 · see citing works
Self-citationCzoty, P. W., Gage, H. D., & Nader, M. A. (2005) · Synapse · doi:10.1002/syn.20200 · Cited by 19 · see citing works
Self-citationHietala, J. A., Kuoppamäki, M., Någren, K., et al. (1997) · Psychopharmacology · doi:10.1007/s002130050356 · Cited by 17 · see citing works
Young (2000) · doi:10.1002/1096-8628(20001009)96:5
Flagged first, then by citations
Cited by
Sorted by citations
Chronic stress, drug use, and vulnerability to addiction
Sinha, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.030 · Cited by 1,904 · see citing works
Impulsivity, compulsivity, and top-down cognitive control
Dalley, J. W., Everitt, B. J., & Robbins, T. W. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.020 · Cited by 1,589 · see citing works
The brain on drugs: from reward to addiction
Volkow, N. D., & Morales, M. (2015) · Cell · doi:10.1016/j.cell.2015.07.046 · Cited by 1,306 · see citing works
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement
Dalley, J. W., Fryer, T. D., Brichard, L., Robinson, E. S. J., Theobald, D. E. H., Lääne, K., Peña, Y., Murphy, E. R., Shah, Y., Probst, K., et al. (2007) · Science · doi:10.1126/science.1137073 · Cited by 1,188 · see citing works
High Impulsivity Predicts the Switch to Compulsive Cocaine-Taking
Belin, D., Mar, A. C., Dalley, J. W., Robbins, T. W., & Everitt, B. J. (2008) · Science · doi:10.1126/science.1158136 · Cited by 989 · see citing works
Everitt, B. J., Belin, D., Economidou, D., Pelloux, Y., Dalley, J. W., & Robbins, T. W. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0089 · Cited by 974 · see citing works
Obesity and addiction: Neurobiological overlaps
Volkow, N. D., Wang, G. ‐., Tomasi, D., & Baler, R. D. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01031.x · Cited by 800 · see citing works
The neural mechanisms of inter-temporal decision-making: understanding variability
Peters, J., & Büchel, C. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.03.002 · Cited by 693 · see citing works
Seo, D., Patrick, C. J., & Kennealy, P. J. (2008) · Aggression and Violent Behavior · doi:10.1016/j.avb.2008.06.003 · Cited by 520 · see citing works
Food and Drug Reward: Overlapping Circuits in Human Obesity and Addiction
Volkow, N. D., Wang, G. J., Fowler, J. S., Tomasi, D., & Baler, R. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2011_169 · Cited by 525 · see citing works
Steeves, T. D. L., Miyasaki, J., Zurowski, M., Lang, A. E., Pellecchia, G., Van Eimeren, T., Rusjan, P., Houle, S., & Strafella, A. P. (2009) · Brain · doi:10.1093/brain/awp054 · Cited by 502 · see citing works
The Addictive Dimensionality of Obesity
Volkow, N. D., Wang, G.-J., Tomasi, D., & Baler, R. D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.020 · Cited by 380 · see citing works
Flagel, S. B., Robinson, T. E., Clark, J. J., Clinton, S. M., Watson, S. J., Seeman, P., Phillips, P. E. M., & Akil, H. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.142 · Cited by 339 · see citing works
Ashok, A. H., Mizuno, Y., Volkow, N. D., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0135 · Cited by 330 · see citing works
The role of the striatum in social behavior
Báez-Mendoza, R., & Schultz, W. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00233 · Cited by 312 · see citing works
The contribution of brain reward circuits to the obesity epidemic
Stice, E., Figlewicz, D. P., Gosnell, B. A., Levine, A. S., & Pratt, W. E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.001 · Cited by 274 · see citing works
Ghahremani, D. G., Lee, B., Robertson, C. L., Tabibnia, G., Morgan, A. T., De Shetler, N., Brown, A. K., Monterosso, J. R., Aron, A. R., Mandelkern, M. A., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4284-11.2012 · Cited by 227 · see citing works
Improving translation of animal models of addiction and relapse by reverse translation
Venniro, M., Banks, M. L., Heilig, M., Epstein, D. H., & Shaham, Y. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0378-z · Cited by 212 · see citing works
Parallel maturation of goal-directed behavior and dopaminergic systems during adolescence
Naneix, F., Marchand, A. R., Di Scala, G., Pape, J.-R., & Coutureau, E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3080-12.2012 · Cited by 209 · see citing works
Clark, L., Stokes, P. R., Wu, K., Michalczuk, R., Benecke, A., Watson, B. J., Egerton, A., Piccini, P., Nutt, D. J., Bowden-Jones, H., et al. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.067 · Cited by 193 · see citing works
Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems
George, O., Le Moal, M., & Koob, G. F. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.11.004 · Cited by 184 · see citing works
Phasic dopamine release in appetitive behaviors and drug addiction
Wanat, M., Willuhn, I., Clark, J., & Phillips, P. (2009) · Current Drug Abuse Reviewse · doi:10.2174/1874473710902020195 · Cited by 177 · see citing works
Lubman, D. I., Yücel, M., Kettle, J. W. L., Scaffidi, A., MacKenzie, T., Simmons, J. G., & Allen, N. B. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.522 · Cited by 176 · see citing works
Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity
Trifilieff, P., & Martinez, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.031 · Cited by 171 · see citing works
Neuroimaging for drug addiction and related behaviors
Parvaz, M. A., Alia-Klein, N., Woicik, P. A., Volkow, N. D., & Goldstein, R. Z. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.055 · Cited by 151 · see citing works
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works
Besson, M., Belin, D., McNamara, R., Theobald, D. E., Castel, A., Beckett, V. L., Crittenden, B. M., Newman, A. H., Everitt, B. J., Robbins, T. W., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.162 · Cited by 143 · see citing works
Sensation-seeking: dopaminergic modulation and risk for psychopathology
Norbury, A., & Husain, M. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.015 · Cited by 142 · see citing works
21st century neurobehavioral theories of decision making in addiction: Review and evaluation
Bickel, W. K., Mellis, A. M., Snider, S. E., Athamneh, L. N., Stein, J. S., & Pope, D. A. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.09.009 · Cited by 134 · see citing works
A systematic review of impulse control disorders in Parkinson’s disease.
Callesen, M. B., Scheel-Krüger, J., Kringelbach, M. L., & Møller, A. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120165 · Cited by 130 · see citing works
Burger, K. S., & Stice, E. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.027003 · Cited by 122 · see citing works
Büchel, C., Peters, J., Banaschewski, T., Bokde, A. L. W., Bromberg, U., Conrod, P. J., Flor, H., Papadopoulos, D., Garavan, H., Gowland, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms14140 · Cited by 118 · see citing works
Zijlstra, F., Booij, J., van den Brink, W., & Franken, I. H. A. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.11.002 · Cited by 109 · see citing works
Depression and impulse control disorders in Parkinson׳s disease: two sides of the same coin?
Vriend, C., Pattij, T., van der Werf, Y. D., Voorn, P., Booij, J., Rutten, S., Berendse, H. W., & van den Heuvel, O. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.001 · Cited by 106 · see citing works
Thanos, P. K., Michaelides, M., Benveniste, H., Wang, G. J., & Volkow, N. D. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.05.020 · Cited by 100 · see citing works
Porter, J. N., Olsen, A. S., Gurnsey, K., Dugan, B. P., Jedema, H. P., & Bradberry, C. W. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5426-10.2011 · Cited by 97 · see citing works
Besson, M., Pelloux, Y., Dilleen, R., Theobald, D. E., Lyon, A., Belin-Rauscent, A., Robbins, T. W., Dalley, J. W., Everitt, B. J., & Belin, D. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.95 · Cited by 81 · see citing works
Beveridge, T. J. R., Smith, H. R., Nader, M. A., & Porrino, L. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.135 · Cited by 64 · see citing works
Self-citationStokes, P. R., Egerton, A., Watson, B., Reid, A., Lappin, J., Howes, O. D., Nutt, D. J., & Lingford-Hughes, A. R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111414090 · Cited by 63 · see citing works
Centonze, D., Rossi, S., Napoli, I., Mercaldo, V., Lacoux, C., Ferrari, F., Ciotti, M. T., De Chiara, V., Prosperetti, C., Maccarrone, M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0548-07.2007 · Cited by 59 · see citing works
Caprioli, D., Hong, Y. T., Sawiak, S. J., Ferrari, V., Williamson, D. J., Jupp, B., Adrian Carpenter, T., Aigbirhio, F. I., Everitt, B. J., Robbins, T. W., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.44 · Cited by 58 · see citing works
Cocaine addiction as a homeostatic reinforcement learning disorder.
Keramati, M., Durand, A., Girardeau, P., Gutkin, B., & Ahmed, S. H. (2017) · Psychological Review · doi:10.1037/rev0000046 · Cited by 44 · see citing works
Novak, G., Seeman, P., & Foll, B. L. (2010) · International Journal of Neuroscience · doi:10.3109/00207454.2010.513462 · Cited by 42 · see citing works
Czoty, P. W., Gage, H. D., & Nader, M. A. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1756-4 · Cited by 40 · see citing works
Self-citationStress as a Risk Factor for Substance Use Disorders: A Mini-Review of Molecular Mediators
Mukhara, D., Banks, M. L., & Neigh, G. N. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00309 · Cited by 26 · see citing works
Lee, J., Parish, C. L., Tomas, D., & Horne, M. K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.055 · Cited by 19 · see citing works
- Authors
- Nader, M. A., Morgan, D., Gage, H. D., Nader, S. H., Calhoun, T. L., Buchheimer, N., Ehrenkaufer, R., & Mach, R. H.
- Affiliations
- Wake Forest University Health Sciences (US)
- University of Florida Health (US)
- Washington University in St. Louis (US)
- Corresponding author
- Nader, Michael A
- Venue
- Nature Neuroscience
- Published
- 2006-07-09
- Volume
- 9
- Issue
- 8
- Pages
- 1050-1056
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2125364966
- Cited by
- 481
- References
- 47
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 16 · 2023: 14 · 2022: 13 · 2021: 12 · 2020: 38 · 2019: 17 · 2018: 22 · 2017: 25 · 2016: 19 · 2015: 33 · 2014: 25 · 2013: 53 · 2012: 36
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01da008468-03)
- National Institute on Drug Abuse (DA-08468, DA 14637, R01DA014637)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- dopamine D2 receptor, cocaine self-administration, cocaine dependence, rhesus monkeys, receptor availability, cocaine reinforcement, abstinence, individual differences, dopaminergic system, chronic cocaine exposure
- MeSH terms
- Animals, Behavior, Animal, Brain, Cocaine, Food, Humans, Lorazepam, Macaca mulatta, Male, Reinforcement, Psychology, Self Administration, Time Factors, Behavior, Addictive, Receptors, Dopamine D2, GABA Modulators, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review